Scientists have found a possible explanation for why cancer patients are less likely to develop Alzheimer's. The enemy of our ...

Promising new approaches to treating gastric cancer have emerged in recent years. These treatments aim to increase patient ...

A Spanish research team has achieved a significant preclinical breakthrough, developing a triple-drug therapy that completely ...

Long-term clinical trials show patients with stage four kidney cancer are living a decade or more beyond previous ...

Pancreatic cancer treatment relies on surgery, chemotherapy, and radiation, with surgery for non-metastatic, technically ...

Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...

A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer ...

Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, ...

Scientists have developed a new nanoparticle-based strategy that could dramatically expand the range of disease-causing proteins that can be targeted by modern medicine. A newly released perspective i ...

The company joins a group of degrader ADC (or DAC) developers that includes Bristol Myers Squibb and Pfizer.

When lung cancer treatment stops working, what happens next? New research reveals the answer may depend on how the cancer ...

A newly uncovered immune chain reaction in the gut may explain why people with inflammatory bowel disease face a much higher ...